Big Move For Oruka Therapeutics, Inc.

Tue, Sep 10, 2024 at 05:30 PM

Oruka Therapeutics, Inc. (ABIO:NASDAQ) shot up at $28.8, representing a gain of 1052%. On Mon, Sep 09, 2024, ABIO:NASDAQ hit a New 6-Month Intraday Low of $2.25. The stock got featured on our News Catalysts scanner on Tue, Sep 03, 2024 at 08:50 AM in the 'MERGER' category. From Mon, Aug 26, 2024, the stock recorded 11.11% Up Days and 80.00% Green Days

About Oruka Therapeutics, Inc. (ABIO:NASDAQ)

ARCA biopharma Inc is a biopharmaceutical company. The Company is engaged in developing genetically-targeted therapies for cardiovascular diseases. Its product candidate is Gencaro.

Top 10 Gainers:

Hempacco Co. Inc. (HPCO:NASDAQ), 1342.86%
Oruka Therapeutics, Inc. (ABIO:NASDAQ), 1052%
Quhuo Limited (QH:NASDAQ), 306.6%
iLearningEngines Holdings Inc Cl A (AILE:NASDAQ), 115.11%
BIO-key International, Inc. (BKYI:NASDAQ), 92.31%
Trevena, Inc. (TRVN:NASDAQ), 53.73%
FibroBiologics Inc. (FBLG:NASDAQ), 49.62%
SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 47.53%
PAVmed Inc. (PAVM:NASDAQ), 43.7%
LightInTheBox Holding Co., Ltd. (LITB:NYSE), 41.18%